‘TARGET My Hives’ a new digital support network for people affected by chronic urticaria - available on Android and iOS

Thursday, June 23, 2016

Exco InTouch, a leading provider of digital health technology, announces the launch of the TARGET My Hives app for Android– the digital healthcare platform is now available in both Android and iOS systems. It is the first digital health community for everyone impacted by chronic urticaria, creating a vital support network that the patients have long needed. By enabling wider communication, it will reduce the sense of isolation that people with the condition often feel; it is about sharing experiences and help. Ultimately, TARGET My Hives seeks to improve patient outcomes by also integrating physicians and patient associations into the network.

Patients with chronic urticaria (commonly referred to as hives), can suffer from sudden occurrence of red, itchy rashes or angioedema with rapid swelling in the deeper layers of the skin.The condition is often triggered by external factors, including sunlight and water, but it can also occur spontaneously, without any identifiable triggers.1 Patients with chronic urticaria are often left alone to cope with the condition and eventually stop seeking help; many have even given up on visiting their doctor.2

TARGET My Hives is already operating successfully, having attracted over 2,000 patient registrations from 61 different countries. Since the iOS app went live in May, the social community for chronic urticaria has developed rapidly with growing levels of active participation. Patients are using the community to communicate with each other, sharing their experiences and giving each other first hand advice – it’s an invaluable support group. The network is providing a platform through which patients have the opportunity to openly discuss their condition and feelings, removing any stigma or sense of isolation felt previously.

Tim Davis, CEO and founder of Exco InTouch commented: “TARGET My Hives” is proving its value in opening up the much needed conversation between people affected and the wider healthcare community. To date, patients have already been reporting how much it is helping them manage their condition, and empowering them to share their own knowledge that may help others. Our mission is to connect everyone, patients, physicians and support groups together. But most importantly, we want to use technology to help patients to actively take control of the condition.

TARGET My Hives will allow patients to learn from others how to manage their disease, set goals for themselves and to share results and outcomes with others. By motivating and supporting each other, TARGET My Hives helps patients to actively take control of their condition. The app also aims to enhance awareness and visibility for patient advocacy groups, acting as a conduit for expanded content and networking opportunities for patients

TARGET My Hives is owned and maintained by Exco InTouch who have extensive experience and a track record of innovation in digital health programs. It is no easy task to develop such a comprehensive support group running across multiple devices and platforms – and Exco InTouch are globally recognized as digital health experts that leverage proven technologies to put patients at the heart of solutions.

Another key factor in the success of their health programs has been the company’s commitment to data privacy and security, an essential component in achieving patient trust, through its partnership with Regulatory Strategies. In fact, two years ahead of the General Data Protection Regulation (GDPR) coming into effect, Exco InTouch introduced a fully compliant regulatory Data Protection Officer. The website and mobile application were developed with funding and support from Novartis Pharma AG.

The app is now available for download on the iTunes App Store and on the Google Play store for Android devices. Find out more on www.myhives.com.

Notes to Editors

About TARGET My Hives

TARGET My Hives will provide a comprehensive support network for patients through stronger engagement with physicians, patient associations group and other people with chronic urticaria.

Through this inclusive approach, and the global patient community it will create, TARGET My Hives will be a powerful tool for physicians to gather leading-edge, real-world data. This will help specialists to advance their knowledge of the disease and ultimately improve treatment outcomes for patients.

About Exco InTouch

Exco InTouch is the leading provider of intelligent Digital Health programs for healthcare and biopharmaceutical companies. Placing the patient at its heart, their proven technology can be employed on any device to create patient engagement and data capture solutions that empower patients to be more involved in their healthcare and ultimately lead to better health outcomes. These solutions capitalize upon global mobile device and internet usage, using mDNA® technology to facilitate secure deployment to patients’ own mobile devices, enabling seamless integration of disease management programs into their daily life. This results in motivated and compliant patients across a wealth of therapeutic, demographic and geographic programs in clinical and commercial settings.

Since 2004, Exco InTouch have engaged with over one million patients across 97 countries, over 26,000 hospitals and clinics and in 70 languages. 16 of the top 20 pharmaceutical companies have deployed their technology.

About Chronic Urticaria

Chronic urticaria (CU) or chronic and severe ‘hives’ (to use the lay term) is an extremely distressing skin condition which has a significant impact on quality of life. CU is characterized by red, swollen, itchy and painful wheals on the skin which may resemble nettle-rash. These wheals reoccur daily for at least six weeks and often for considerably longer. Each wheal generally resolves within 24 hours, but as one wheal resolves others develop so that some people can continuously suffer these symptoms for many years.

The effects of CU on quality of life can be far-reaching; these include sleep deprivation, depression and social isolation. It has been reported that in comparison to some other dermatological and medical conditions, people with urticaria have a significantly worse quality of life.3

For media enquiries, please contact Tristan Jervis or Alex Heeley on +44 (0) 203 735  8166 or e-mail: t.jervis@defacto.com